This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming the fight against obesity. Learn the science, the risks, and the real-world results from experts on the front lines. Take control of ...

The guidance expands the options for preventing and managing high blood pressure, which is a major risk factor for more ...

Photo credit: shutterstock.com/These trendy patches promise Ozempic-like results without the prescription but experts are skeptical If your social media feed is ...

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes ...

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic underpinnings of weight loss response has identified a gene, neurobeachin (NBEA), as ...

The average cost of employer-sponsored health insurance climbed to $16,501 per employee in 2024, up 5% from the previous year, according to results from Mercer’s 2024 National Survey of ...

Demand for GLP-1 drugs is causing spending on traditional drugs to grow at a faster clip than spending on specialty drugs, according to new research. That could put further stress on employers and ...

Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis. In pooled findings from nine studies, patients undergoing endoscopy while taking ...